Schrödinger builds molecular modeling and simulation software and a cloud-based platform used by biopharma, materials companies, and academic and government labs to design therapeutics and materials. It sells software licenses and enterprise deployments and also advances wholly owned and collaborative drug discovery programs. Founded in 1990, the company is headquartered in New York and is publicly traded on NASDAQ under the ticker SDGR.